First Time Loading...
S

Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607

Watchlist Manager
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Watchlist
Price: 17.92 CNY -0.78% Market Closed
Updated: May 5, 2024

Shanghai Pharmaceuticals Holding Co Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shanghai Pharmaceuticals Holding Co Ltd
Net Income (Common) Peer Comparison

Comparables:
1099
600998
C
600511
000963
C
000028

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
S
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Net Income (Common)
¥3.8B
CAGR 3-Years
-6%
CAGR 5-Years
-1%
CAGR 10-Years
5%
Sinopharm Group Co Ltd
HKEX:1099
Net Income (Common)
¥8.9B
CAGR 3-Years
13%
CAGR 5-Years
10%
CAGR 10-Years
15%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Net Income (Common)
¥2.2B
CAGR 3-Years
-7%
CAGR 5-Years
12%
CAGR 10-Years
17%
C
China National Medicines Corp Ltd
SSE:600511
Net Income (Common)
¥2.1B
CAGR 3-Years
16%
CAGR 5-Years
9%
CAGR 10-Years
18%
Huadong Medicine Co Ltd
SZSE:000963
Net Income (Common)
¥2.7B
CAGR 3-Years
-3%
CAGR 5-Years
5%
CAGR 10-Years
17%
C
China National Accord Medicines Corp Ltd
SZSE:000028
Net Income (Common)
¥1.6B
CAGR 3-Years
4%
CAGR 5-Years
6%
CAGR 10-Years
12%

See Also

What is Shanghai Pharmaceuticals Holding Co Ltd's Net Income (Common)?
Net Income (Common)
3.8B CNY

Based on the financial report for Dec 31, 2023, Shanghai Pharmaceuticals Holding Co Ltd's Net Income (Common) amounts to 3.8B CNY.

What is Shanghai Pharmaceuticals Holding Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
5%

Over the last year, the Net Income (Common) growth was -33%. The average annual Net Income (Common) growth rates for Shanghai Pharmaceuticals Holding Co Ltd have been -6% over the past three years , -1% over the past five years , and 5% over the past ten years .